Resilux NV:企業の戦略・SWOT・財務情報

◆英語タイトル:Resilux NV - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4403
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Resilux NV – Strategy, SWOT and Corporate Finance Report
Summary

Resilux NV – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Resilux NV (Resilux) is a plastic packaging solutions provider in Belgium. The company specializes in manufacturing of polyethylene terephthalate (PET) preforms in wide variety of weights, colors and sizes. It also has expertise in blowing preforms into bottles. Resilux uses barrier technologies including ResiOx, ResiMid, ResiMax, ResiBlock and ResiBar Eco to manufacture its products. It also produces preforms made from recycled material. The company’s products find applications in packaging of water, soft drinks, edible oils, ketchup, detergents, milk, beer and fruit juices. It has production facilities in Belgium, Spain, Russia, Greece, Switzerland, Hungary and the US. Resilux is headquartered in Wetteren, Belgium.

Scope

- Detailed information on Resilux NV required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Resilux NV in the form of a SWOT analysis
- An in-depth view of the business model of Resilux NV including a breakdown and examination of key business segments
- Intelligence on Resilux NV’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Resilux NV, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Resilux NV and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Resilux NV as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Resilux NV’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Resilux NV: Company Overview 7
Resilux NV: Overview and Key Facts 7
Resilux NV: Overview 7
Resilux NV: Key Facts 7
Resilux NV: Key Employees 9
Resilux NV: Key Employee Biographies 10
Resilux NV: Major Products and Services 11
Resilux NV: Company History 12
Resilux NV: Management Statement 14
Resilux NV: Locations and Subsidiaries 15
Resilux NV: Key Competitors 17
Resilux NV: Company Analysis 18
Resilux NV: Business Description 18
Resilux NV: SWOT Analysis 19
Resilux NV: SWOT Overview 19
Resilux NV: Strengths 19
Resilux NV: Weaknesses 20
Resilux NV: Opportunities 20
Resilux NV: Threats 21
Resilux NV: Corporate Financial Deals Activity 22
Resilux NV: Financial Deals Overview 22
Resilux NV: Targets and Partners 23
Resilux NV: Top Deals 2014 – 2018YTD* 24
Resilux NV: Mergers and Acquisitions 25
Resilux NV: Private Equity and Ownership 26
Appendix 27
Contact Us 27
Methodology 27
About MarketLine 28

List of Tables
Table 1: Resilux NV: Key Facts
Table 2: Resilux NV: Key Employees
Table 3: Resilux NV: Locations and Subsidiaries
Table 4: Resilux NV: Key Competitors
Table 5: Resilux NV: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Resilux NV: Targets and Partners
Table 7: Resilux NV: Top Deals 2014 - 2018YTD*
Table 8: Resilux NV: M&A Volume and Value Trend (2014 - YTD*2018)
Table 9: Resilux NV: M&A Activity by Geography (2014 - YTD*2018)
Table 10: Resilux NV: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 11: Resilux NV: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

List of Figures
Figure 1: Resilux NV: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Resilux NV: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: Resilux NV: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: Resilux NV: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 5: Resilux NV: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Resilux NV:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oxford Immunotec Ltd:企業の製品パイプライン分析2018
    Summary Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.T …
  • Fuji Electric Co Ltd (6504):企業の財務・戦略的SWOT分析
    Fuji Electric Co Ltd (6504) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Papeles y Cartones de Europa SA:企業の戦略・SWOT・財務情報
    Papeles y Cartones de Europa SA - Strategy, SWOT and Corporate Finance Report Summary Papeles y Cartones de Europa SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Curetis NV (CURE)-医療機器分野:企業M&A・提携分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, im …
  • ObsEva SA (OBSV):企業の財務・戦略的SWOT分析
    ObsEva SA (OBSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • SK Chemicals Co Ltd (006120):企業の財務・戦略的SWOT分析
    Summary SK Chemicals Co Ltd (SK Chemicals) is a chemical company that provides life sciences products and solutions. The company manufactures polyester and acetate yarns for textile, and industrial uses. Its copolyesters comprise ecozen, skygreen and skypets. SK Chemicals provides high-performance r …
  • WNS (Holdings) Limited:企業の戦略・SWOT・財務情報
    WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Metro AG:戦略・SWOT・企業財務分析
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • ConSynance Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ConSynance Therapeutics Inc (ConSynance Therapeutics), formerly Concerted Therapeutics Inc is a drug discovery company that concentrates on the development of new therapeutic solutions for unmet medical needs. The company provides pipeline programs such as CSTI-100, CSTI-200, and CSTI-300, a …
  • Prysmian S.p.A.:企業の戦略・SWOT・財務情報
    Prysmian S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Prysmian S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務情報
    Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Trinity Biotech Plc (TRIB)-医療機器分野:企業M&A・提携分析
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • KDDI Corporation (9433):企業の財務・戦略的SWOT分析
    KDDI Corporation (9433) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Biocept Inc (BIOC):企業の財務・戦略的SWOT分析
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Pharmacyclics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmacyclics Inc (Pharmacyclics), a wholly-owned subsidiary of AbbVie, discovers, develops and commercializes novel therapies for the treatment of cancer and immunemediated diseases. The company’s drugs and drug candidates are synthetic small-molecules that target major biochemical pathways …
  • Elmet Technologies, Inc.:企業の戦略・SWOT・財務情報
    Elmet Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Elmet Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • High Peak Royalties Limited (HPR):企業の財務・戦略的SWOT分析
    High Peak Royalties Limited (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • EyePoint Pharmaceuticals Inc (PSDV):企業の製品パイプライン分析2018
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • Bio Techne Corp (TECH):製薬・医療:M&Aディール及び事業提携情報
    Summary Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆